tiprankstipranks
GRI Bio expects cash to fund operations into Q3 of 2024
PremiumThe FlyGRI Bio expects cash to fund operations into Q3 of 2024
8d ago
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
8d ago
GRI Bio files $75M mixed securities shelf
PremiumThe Fly
GRI Bio files $75M mixed securities shelf
11d ago
GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference
PremiumPress ReleasesGRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference
1M ago
GRI Bio sees cash runway into 3Q24
PremiumThe Fly
GRI Bio sees cash runway into 3Q24
2M ago
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
2M ago
GRI Bio receives MRHA authorization to conduct Phase 2a study of GRI-0621
PremiumThe FlyGRI Bio receives MRHA authorization to conduct Phase 2a study of GRI-0621
3M ago
GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom
PremiumPress Releases
GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdom
3M ago
GRI Bio Announces Offering Pricing Details
PremiumCompany Announcements
GRI Bio Announces Offering Pricing Details
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100